Global private equity firm Advent International will acquire a 50.1% stake in Suven Pharma, buying 12.75 crore shares for a total of Rs 6,313 crore. Suven Pharma MD Venkateswarlu Jasti discusses the acquisition.
GET REGULAR UPDATES

MUST WATCH VIDEOS

IPO Adda | Indegene Management On IPO Plans | NDTV Profit

IPO Adda | Aadhar Housing Finance MD & CEO Discusses Plans | NDTV Profit

NDTV Profit

IGX MD & CEO Rajesh Mediratta On New Small Scale LNG Contracts | NDTV Profit

NDTV Profit

TBO Tek To Launch Rs 1,550 Crore IPO | NDTV Profit

NDTV Profit

Indeed India's Sashi Kumar On Hiring Trends In India | NDTV Profit

NDTV Profit

Star Health's Q4 Report: Post-Hike Trends Discussed With Nilesh Kambli; Multiple Banking Partnerships

NDTV Profit

View All